856 Routine Baseline Blood Tests Predicting Pembrolizumab Sensitivity in Advanced High-Grade Serous Ovarian Cancer (AHGSOC) 1st Line Therapy: Substudy from the NEOPEMBROV/GINECO (NCT03275506) Randomized Trial
International Journal of Gynecological Cancer(2024)
Key words
Biomarkers for Immunotherapy,Immune Responses
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined